Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
Division of Rheumatology, Department of Medicine.
Blood Adv. 2018 Nov 13;2(21):2959-2963. doi: 10.1182/bloodadvances.2018023911.
can be mutated in individuals diagnosed with unicentric and idiopathic multicentric Castleman disease. Defective lymphocyte apoptosis may be a pathological mechanism shared between Castleman disease and autoimmune lymphoproliferative syndrome.
可发生于诊断为局灶型和特发性多中心 Castleman 病的个体中。淋巴细胞凋亡缺陷可能是 Castleman 病和自身免疫性淋巴组织增生综合征之间共有的病理机制。